Spherix Global Insights

Spherix Global Insights company information, Employees & Contact Information

Spherix Global Insights is a leading provider of market research, business intelligence and advisory services to the global life sciences industry. The company’s unique service offerings are powered by deep therapeutic knowledge, the Spherix Network specialty physician panel, and commercially relevant analyses to enable strategic decision-making by our valued customers. A trusted advisor and industry thought leader, Spherix Global Insights provides specialized market expertise in six (6) focused therapeutic areas including: dermatology, gastroenterology, nephrology, neurology, rheumatology and ophthalmology.
Looking for a particular Spherix Global Insights employee's phone or email?

Spherix Global Insights Questions

News

Spherix Global Insights Expands Hematology Franchise to Include Oncology, Enhancing Advisory Services and Delivering Deeper Physician and Market Insights - Yahoo Finance

Spherix Global Insights Expands Hematology Franchise to Include Oncology, Enhancing Advisory Services and Delivering Deeper Physician and Market Insights Yahoo Finance

US Rheumatologists View Cell Therapy as a Potential Game - GlobeNewswire

US Rheumatologists View Cell Therapy as a Potential Game GlobeNewswire

Spherix Global Insights Highlights Patient Influence in Shaping PNH Treatment Choices - The Manila Times

Spherix Global Insights Highlights Patient Influence in Shaping PNH Treatment Choices The Manila Times

Access Barriers Hamper Early Line Adoption of UCB’s Bimzelx - GlobeNewswire

Access Barriers Hamper Early Line Adoption of UCB’s Bimzelx GlobeNewswire

Despite Early Low Awareness, Physicians Forecast Swift Adoption of Novo Nordisk’s Wegovy in MASH, According to Spherix Global Insights - Yahoo Finance

Despite Early Low Awareness, Physicians Forecast Swift Adoption of Novo Nordisk’s Wegovy in MASH, According to Spherix Global Insights Yahoo Finance

Markets - Medicine Hat News - FinancialContent

Markets - Medicine Hat News FinancialContent

New Spherix Global Insights Data Reveals 85% of FSGS Patients Have Actively Progressing Disease Despite Treatment, Underscoring Urgent Demand for Innovative Treatments - Yahoo Finance

New Spherix Global Insights Data Reveals 85% of FSGS Patients Have Actively Progressing Disease Despite Treatment, Underscoring Urgent Demand for Innovative Treatments Yahoo Finance

Gene and Oral Therapies Drive Urgency and Innovation in - GlobeNewswire

Gene and Oral Therapies Drive Urgency and Innovation in GlobeNewswire

Tremfya’s Promising Debut Boosts Momentum for IL-23 Class in Ulcerative Colitis Treatment, According to Spherix Global Insights - HCPLive

Tremfya’s Promising Debut Boosts Momentum for IL-23 Class in Ulcerative Colitis Treatment, According to Spherix Global Insights HCPLive

Spherix Global Insights Launches New Portal Providing Seamless Client Access to Subscribed Data and Insights - PR Newswire

Spherix Global Insights Launches New Portal Providing Seamless Client Access to Subscribed Data and Insights PR Newswire

GSK’s Linerixibat Poised to Address Substantial Unmet Need for the Treatment of Pruritus Associated with Primary Biliary Cholangitis, According to Spherix Global Insights - Yahoo Finance

GSK’s Linerixibat Poised to Address Substantial Unmet Need for the Treatment of Pruritus Associated with Primary Biliary Cholangitis, According to Spherix Global Insights Yahoo Finance

Spherix Global Insights Identifies Emerging Trends in Market Access Across More Than Twenty Key Therapeutic Areas - The Manila Times

Spherix Global Insights Identifies Emerging Trends in Market Access Across More Than Twenty Key Therapeutic Areas The Manila Times

Hemophilia Specialists Raise the Bar: Quality of Life and Innovation Drive Market Reordering - FinancialContent

Hemophilia Specialists Raise the Bar: Quality of Life and Innovation Drive Market Reordering FinancialContent

As Roche/Genentech’s Obinutuzumab (Gazyva) Nears FDA Decision, Spherix Global Insights White Paper Reveals Keys to Successful Lupus Product Launches - Yahoo Finance

As Roche/Genentech’s Obinutuzumab (Gazyva) Nears FDA Decision, Spherix Global Insights White Paper Reveals Keys to Successful Lupus Product Launches Yahoo Finance

Sjögren’s Disease Remains an Underdiagnosed and Underguided Condition, Creating an Opening for Manufacturers to Shape the Future of Care, According to Spherix Global Insights - Yahoo Finance

Sjögren’s Disease Remains an Underdiagnosed and Underguided Condition, Creating an Opening for Manufacturers to Shape the Future of Care, According to Spherix Global Insights Yahoo Finance

Spherix Global Insights Expands into Financial Services, Empowering Asset Managers and Hedge Funds with Critical Pharmaceutical Market Insights - Yahoo Finance

Spherix Global Insights Expands into Financial Services, Empowering Asset Managers and Hedge Funds with Critical Pharmaceutical Market Insights Yahoo Finance

Critical Inflection Point in FSGS on the Horizon with Nephrologists Poised to Rapidly Adopt New Therapies, According to Spherix Global Insights - Yahoo Finance

Critical Inflection Point in FSGS on the Horizon with Nephrologists Poised to Rapidly Adopt New Therapies, According to Spherix Global Insights Yahoo Finance

Rheumatologists Eagerly Anticipate Pipeline Advancements in Idiopathic Inflammatory Myopathies to Address Deep Unmet Need, According to Spherix Global Insights - Yahoo Finance

Rheumatologists Eagerly Anticipate Pipeline Advancements in Idiopathic Inflammatory Myopathies to Address Deep Unmet Need, According to Spherix Global Insights Yahoo Finance

Takeda’s Eohilia Sees Strong Early Adoption and Growth Potential in Eosinophilic Esophagitis, According to Spherix Global Insights - Yahoo Finance

Takeda’s Eohilia Sees Strong Early Adoption and Growth Potential in Eosinophilic Esophagitis, According to Spherix Global Insights Yahoo Finance

Critical Gaps in FSGS Treatment Highlight Need for New - GlobeNewswire

Critical Gaps in FSGS Treatment Highlight Need for New GlobeNewswire

Spherix Global Insights Releases 2020 Corporate Highlights and Shares Outlook for 2021 - PR Newswire

Spherix Global Insights Releases 2020 Corporate Highlights and Shares Outlook for 2021 PR Newswire

Markets - Medicine Hat News - FinancialContent

Markets - Medicine Hat News FinancialContent

EMD Serono's Mavenclad and Novartis' Kesimpta Emerging as Growth Brands After Eventful 2021 for the Multiple Sclerosis Market in Canada, According to Spherix Global Insights - PR Newswire

EMD Serono's Mavenclad and Novartis' Kesimpta Emerging as Growth Brands After Eventful 2021 for the Multiple Sclerosis Market in Canada, According to Spherix Global Insights PR Newswire

Top Spherix Global Insights Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant